Association of ITPA Genotype with Event-Free Survival and Relapse Rates in Children with Acute Lymphoblastic Leukemia Undergoing Maintenance Therapy | PLOS ONE
![Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram](https://www.researchgate.net/publication/232226400/figure/fig1/AS:202969929785350@1425403210630/Event-free-survival-EFS-curves-for-children-with-acute-lymphoblastic-leukemia-according.png)
Event-free survival (EFS) curves for children with acute lymphoblastic... | Download Scientific Diagram
![Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation - ScienceDirect Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497121006340-grabsf1.jpg)
Prognostic factors for CNS control in children with acute lymphoblastic leukemia treated without cranial irradiation - ScienceDirect
![The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1ce7ce21-b16c-4b53-93fa-7c5a765fb623/cam42096-fig-0002-m.jpg)
The effect of adopting pediatric protocols in adolescents and young adults with acute lymphoblastic leukemia in pediatric vs adult centers: An IMPACT Cohort study - Gupta - 2019 - Cancer Medicine - Wiley Online Library
![Kaplan–Meyer estimate of overall survival (OS) and event-free survival... | Download Scientific Diagram Kaplan–Meyer estimate of overall survival (OS) and event-free survival... | Download Scientific Diagram](https://www.researchgate.net/publication/275058004/figure/fig1/AS:267478706159674@1440783301727/Kaplan-Meyer-estimate-of-overall-survival-OS-and-event-free-survival-EFS-of-children.png)
Kaplan–Meyer estimate of overall survival (OS) and event-free survival... | Download Scientific Diagram
![Outcome (overall survival, OS blue, and event-free survival, EFS red)... | Download Scientific Diagram Outcome (overall survival, OS blue, and event-free survival, EFS red)... | Download Scientific Diagram](https://www.researchgate.net/publication/338776208/figure/fig3/AS:960056971505665@1605906827030/Outcome-overall-survival-OS-blue-and-event-free-survival-EFS-red-of-pediatric-and.png)
Outcome (overall survival, OS blue, and event-free survival, EFS red)... | Download Scientific Diagram
![Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 | Leukemia Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 | Leukemia](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41375-018-0071-7/MediaObjects/41375_2018_71_Fig1_HTML.jpg)
Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012 | Leukemia
Kaplan-Meier curves for event-free survival (A), transformation-free... | Download Scientific Diagram
New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia | Haematologica
![Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study | HTML Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study | HTML](https://www.mdpi.com/cancers/cancers-12-02044/article_deploy/html/images/cancers-12-02044-g001.png)
Cancers | Free Full-Text | Real-World Outcomes of Patients with Refractory or Relapsed FLT3-ITD Acute Myeloid Leukemia: A Toulouse-Bordeaux DATAML Registry Study | HTML
Relapses and treatment-related events contributed equally to poor prognosis in children with ABL-class fusion positive B-cell acute lymphoblastic leukemia treated according to AIEOP-BFM protocols | Haematologica
![Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbjc.2017.462/MediaObjects/41416_2018_Article_BFbjc2017462_Fig2_HTML.jpg)
Enrolling children with acute lymphoblastic leukaemia on a clinical trial improves event-free survival: a population-based study | British Journal of Cancer
![Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor - Clinical Lymphoma, Myeloma and Leukemia Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor - Clinical Lymphoma, Myeloma and Leukemia](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6c19f8bf-478d-4667-b62b-bca4ac9f4ee7/gr1.jpg)
Early BCR-ABL1 Reduction Is Predictive of Better Event-free Survival in Patients With Newly Diagnosed Chronic Myeloid Leukemia Treated With Any Tyrosine Kinase Inhibitor - Clinical Lymphoma, Myeloma and Leukemia
![Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia - ScienceDirect Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2152265019320154-gr1.jpg)
Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia - ScienceDirect
![The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram](https://www.researchgate.net/publication/332022333/figure/fig3/AS:960056870830082@1605906803319/The-Kaplan-Meier-analysis-of-5-year-event-free-survival-and-overall-survival-in-children.png)
The Kaplan–Meier analysis of 5-year event-free survival and overall... | Download Scientific Diagram
![Overall survival (a) and event-free survival (b) of adult acute... | Download High-Resolution Scientific Diagram Overall survival (a) and event-free survival (b) of adult acute... | Download High-Resolution Scientific Diagram](https://www.researchgate.net/publication/322210177/figure/fig1/AS:960056845668361@1605906797919/Overall-survival-a-and-event-free-survival-b-of-adult-acute-lymphoblastic-leukemia.gif)
Overall survival (a) and event-free survival (b) of adult acute... | Download High-Resolution Scientific Diagram
A) Overall survival and (B) event-free survival of 58 patients with... | Download Scientific Diagram
![Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology](https://ascopubs.org/na101/home/literatum/publisher/asco/journals/content/jco/2021/jco.2021.39.issue-28/jco.20.03048/20210921/images/large/jco.20.03048t1.jpeg)
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531 | Journal of Clinical Oncology
![Event-free survival (EFS) of patients with acute promylocytic leukemia... | Download Scientific Diagram Event-free survival (EFS) of patients with acute promylocytic leukemia... | Download Scientific Diagram](https://www.researchgate.net/publication/262045183/figure/fig2/AS:392504168992769@1470591694353/Event-free-survival-EFS-of-patients-with-acute-promylocytic-leukemia-APL-according-to.png)
Event-free survival (EFS) of patients with acute promylocytic leukemia... | Download Scientific Diagram
![A) Overall survival and (B) event-free survival for the subgroup of... | Download Scientific Diagram A) Overall survival and (B) event-free survival for the subgroup of... | Download Scientific Diagram](https://www.researchgate.net/publication/253339574/figure/fig4/AS:601721768267779@1520473057214/A-Overall-survival-and-B-event-free-survival-for-the-subgroup-of-patients-with-acute.png)
A) Overall survival and (B) event-free survival for the subgroup of... | Download Scientific Diagram
Pharmacogenetic Analysis of Pediatric Patients with Acute Lymphoblastic Leukemia: A Possible Association between Survival Rate and ITPA Polymorphism | PLOS ONE
![Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease Treatment response, survival, safety, and predictive factors to chimeric antigen receptor T cell therapy in Chinese relapsed or refractory B cell acute lymphoblast leukemia patients | Cell Death & Disease](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41419-020-2388-1/MediaObjects/41419_2020_2388_Fig2_HTML.png)